Taranta A, Elmonem MA, Bellomo F, De Leo E, Boenzi S, Janssen MJ, Jamalpoor A, Cairoli S, Pastore A, De Stefanis C, Colucci M, Rega LR, Giovannoni I, Francalanci P, van den Heuvel LP, Dionisi-Vici C, Goffredo BM, Masereeuw R, Levtchenko E, Emma F (2021) Benefits and toxicity of disulfiram in preclinical models of nephropathic cystinosis
What we know Eli Lilly, the pharmaceutical company behind GLP-1 injection Zepbound, is working to bring its weight loss drug to the market in pill form
69% of patients achieved more than 10% weight loss compared to 9% on placebo
Leehey, D.J., Rahman, M.A., Borys, E., Picken, M.M
TRIUMPH-4 uses efficacy estimand (on-treatment)
Users report feeling less hungry and more satisfied after meals, contributing to weight loss